Cargando…

Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity

BACKGROUND: HF10 is a highly attenuated type 1 herpes simplex virus (HSV) with proven effective oncolytic effect. Previous investigations have demonstrated that colon cancer mice model treated with HF10 not only had better survival but were also resistant to the reimplantation of the antitumor effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hotta, Yoshihiro, Kasuya, Hideki, Bustos, Itzel, Naoe, Yoshinori, Ichinose, Toru, Tanaka, Maki, Kodera, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357077/ https://www.ncbi.nlm.nih.gov/pubmed/28331843 http://dx.doi.org/10.2147/OV.S127179

Ejemplares similares

Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
por: Abdelmoneim, Mohamed, et al.
Publicado: (2022)

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2017)

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
por: Hirooka, Yoshiki, et al.
Publicado: (2018)

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
por: Miyajima, Noriyuki, et al.
Publicado: (2021)

C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells
por: Morimoto, Daishi, et al.
Publicado: (2021)

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2018)

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth
por: Wu, Zhiwen, et al.
Publicado: (2019)

The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
por: Abdelmoneim, Mohamed, et al.
Publicado: (2023)

GASTRIC CANCER WITH MINIMAL PERITONEAL METASTASIS: IS THIS A SIGN TO GIVE UP OR TO TREAT MORE AGGRESSIVELY?
por: KODERA, YASUHIRO
Publicado: (2013)

Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?
por: Kodera, Yasuhiro
Publicado: (2018)

Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
por: Sawaki, Koichi, et al.
Publicado: (2020)

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
por: Umeda, Shinichi, et al.
Publicado: (2017)

Few-layer HfS(2) transistors
por: Kanazawa, Toru, et al.
Publicado: (2016)

Joint Degree Program for Graduate Students at the Nagoya University Graduate School of Medicine
por: Kasuya, Hideki, et al.
Publicado: (2019)

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy
por: Miwa, Takashi, et al.
Publicado: (2019)

Non-curative surgery for patients with gastric cancer with local peritoneal metastasis: A retrospective cohort study
por: Dong, Yuanqiang, et al.
Publicado: (2016)

Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer
por: Kanda, Mitsuro, et al.
Publicado: (2020)

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
por: Shimizu, Dai, et al.
Publicado: (2017)

Problem-Based Learning in Child and Adolescent Psychiatry: A Perspective from Japan
por: Iwatsuki, Junko, et al.
Publicado: (2021)

Reduced expression of exosomal miR-29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement
por: Ohzawa, Hideyuki, et al.
Publicado: (2020)

Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long‐term follow‐up study
por: Bang, Kyunghye, et al.
Publicado: (2022)

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy
por: Tanaka, Takaaki, et al.
Publicado: (2012)

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
por: Outani, Hidetatsu, et al.
Publicado: (2014)

Role of Peritoneal Lavage Cytology and Prediction of Prognosis and Peritoneal Recurrence After Curative Surgery for Colorectal Cancer
por: Bae, Sung Joon, et al.
Publicado: (2014)

Murine Liver Metastasis Model Using L5178Y‐ML Lymphoma and the Effect of Antitumor Agents on the Metastasis
por: Watanabe, Yoshinori, et al.
Publicado: (1988)

LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer
por: Nagata, Hiroshi, et al.
Publicado: (2019)

Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
por: Naoe, Yoshinori, et al.
Publicado: (1998)

Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2019)

Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
por: Yamamoto, Tomohisa, et al.
Publicado: (2022)

Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer
por: Shimizu, Dai, et al.
Publicado: (2018)

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer
por: Sakata, Kazuki, et al.
Publicado: (2022)

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma
por: Kanda, Mitsuro, et al.
Publicado: (2017)

Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2017)

GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
por: Shimizu, Dai, et al.
Publicado: (2017)

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021)

STOP-HF: Expanding the role of HF programs into the community
por: ElMaghawry, Mohamed, et al.
Publicado: (2014)

Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery?
por: Portolani, Nazario, et al.
Publicado: (2014)

Role for Daple in non‐canonical Wnt signaling during gastric cancer invasion and metastasis
por: Ara, Hosne, et al.
Publicado: (2015)

Intrabiliary growth type of metastasis from colon cancer, 12 years after curative colectomy: a case report
por: Sasaki, Shin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sivem8snaf9o22lpoujcnfvb4r